Used as a potent inhibitor in targeted cancer therapies, particularly in the development of kinase inhibitors for treating solid tumors. It shows strong activity against specific tyrosine kinases involved in cell proliferation and survival pathways. Due to its high selectivity and binding affinity, it is employed in research and development of anti-tumor agents, especially in non-small cell lung cancer and other malignancies driven by aberrant kinase signaling. Its structure enables enhanced cellular permeability and metabolic stability, making it a valuable scaffold in oncology drug discovery.